Dracorhodin perchlorate, an anthocyanin red pigment, induces human melanoma A375-S2 cell death through the apoptotic pathway. Caspase-3, -8, -9, and -10 inhibitors partially reversed the cell death induced by dracorhodin perchlorate. Caspase-3 and -8 were activated, followed by the degradation of caspase-3 substrates, the inhibitor of caspase-activated DNase, and poly-(ADP-ribose) polymerase. Dracorhodin perchlorate upregulated the expression ratio of Bax/Bcl-2 and significantly increased the expression of p53 and p21 
Dracorhodin perchlorate (Fig. 1A) is a synthetic analogue of the antimicrobial anthocyanin red pigment dracorhodin (Fig. 1B) , which is isolated in the exudates of the fruit of Daemonorops draco, [1] [2] [3] known as "dragon's blood" in traditional Chinese medicine 4) and as Kirin-kakketsu in Japanese. It has been used for the treatment of injuries and bleeding. Many flavonoids have been reported to induce apoptosis in human tumor cells, [5] [6] [7] and therefore the cytotoxic effect of dracorhodin perchlorate on human melanoma A375-S2 cells is examined in the present study.
Numerous anticancer drugs exert their therapeutic action by inducing apoptosis in various malignant cells. A variety of proteins and genes are involved in apoptosis. Caspases are a family of cysteine proteases that mediate apoptosis. Binding of death ligands such as FasL to their cognate receptors triggers the extrinsic pathway, leading to activation of caspases-8 and -10. Cellular stresses such as UV irradiation result in engagement of the intrinsic cell death pathway leading to procaspase-9 and -2 activation. Both pathways lead to a cascade of executioner caspases (-3, -6, -7), which results in the cleavage of a number of caspase substrates responsible for apoptotic demise of the cells by cleaving intracellular proteins, altering or negating protein functions. [8] [9] [10] [11] The Bcl-2 protein family is a large family of apoptosisregulating proteins that modulate the mitochondrial pathway. It includes both antiapoptotic proteins, such as Bcl-2 and Bcl-X L , and proapoptotic proteins such as Bax and Bak. 12) These proteins regulate mitochondrial membrane permeability, either promoting or suppressing the release of apoptogenic proteins from these organelles. 13) The tumor suppressor p53 plays an important role in regulating the expression of genes that mediate cell cycle arrest and/or apoptosis in response to genotoxic insults. 14) Following environmental insults, p53 is activated by posttranslational modifications such as phosphorylation and acetylation which increase its protein stability and enhance its DNA binding activity. 15) Activated p53 upregulates expression of downstream target genes, including Bax, 16) p53-upregulated modulator of apoptosis (PUMA), 17) and cell-cycle regulator p21 WAF1 , 18, 19) and thus elevated p53 activity results in either cell cycle arrest or direct cell death.
The mitogen-activated protein kinases (MAPKs) include extracellular signal-regulated kinase (ERK), c-Jun NH2-terminal protein kinase (JNK), and p38 kinase. ERK is generally considered to be a survival mediator involved in the protective actions of growth factors in apoptosis, 20, 21) whereas p38 and JNK are usually referred to as stress-stimulated MAPKs, which are required for the induction of apoptosis by diverse stimuli such as UV irradiation, oxidants, and anti-cancer drugs. [22] [23] [24] In the present paper, we report that dracorhodin perchlorate induces apoptosis in human melanoma A375-S2 cells via accumulation of p53, altered Bax/Bcl-2 level, and activation of caspases and p38/JNK MAPKs.
MATERIALS AND METHODS

Chemical Reagents
Dracorhodin perchlorate was purchased from Beijing Institute of Biological Products (Beijing, China). The purity of dracorhodin perchlorate was measured by HPLC and determined to be about 98%. This compound was dissolved in dimethyl sulfoxide (Me 2 SO), and the Me 2 SO concentration in all cell cultures was kept at less than below 0.1% which had no detectable effect on cell growth or apoptosis.
Pan-caspase inhibitor (z-VAD-fmk), and caspase-3 (z-DEVD-fmk), capase-8 (z-IETD-fmk), caspase-9 (z-LEHDfmk), and caspase-10 (z-AEVD-fmk) inhibitors were obtained from Enzyme Systems (Livermore, CA, U.S.A.). AntiFas agonistic antibody CH-11 was from Medical & Biological Laboratories (Nagoya, Japan). SB203580 and PD98059 were from Calbiochem (La Jalla, CA, U.S.A.), and SP600125 was from Alexis (Lausen, Swizerland). Wortmannin and genistein were obtained from Sigma (St. Louis, MO, U.S.A.).
Cell Culture The human malignant melanoma A375-S2 cell line (#CRL-1872) was obtained from the American Type Culture Collection (ATCC, Rockville, MD, U.S.A.). The cells were cultured in RPMI-1640 medium (Gibco, Grand Island, NY, U.S.A.) containing 10% fetal bovine serum (FBS) (Yuanhengshengma Biological Reagent Institute, Beijing, China) and 0.03% l-glutamine (Gibco) in 5% CO 2 at 37°C. The cells in the exponential phase of growth were used in the experiments.
Cytotoxicity Assay All the cells were cultured at 5ϫ10 3 cells/well in 96-well plates (Nunc, Roskilde, Denmark). After preincubation with the caspase inhibitors z-VAD-fmk, z-DEVD-fmk, z-IETD-fmk, z-LEHD-fmk, and z-AEVD-fmk at given concentrations for 1 h, the cells were incubated with or without dracorhodin perchlorate for 12 h. Cell growth was measured at different time points in the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as previously described with a plate reader (Tecan, Austria). 25) Observation of Morphologic Changes A375-S2 cells in RPMI-1640 containing 10% FBS were seeded into 25 ml culture bottles and incubated overnight. Dracorhodin perchlorate 60 mM was added to the cell culture, and the cellular morphology was observed using phase-contrast microscopy (Leica, Germany) at the indicated times.
Nuclear Damage Observed with Hoechst 33258 Staining The cells in RPMI-1640 containing 10% FBS were seeded into 6-well plates and incubated overnight. Dracorhodin perchlorate 60 mM was added to the cell culture and incubated for the indicated times. The cells were fixed with 3.7% paraformaldelyde at room temperature for 2 h, then washed twice with Ca 2ϩ -and Mg 2ϩ -free phosphate-buffered saline (PBS) and stained with Hoechst 33258 (Sigma) 167 mM at 37°C for 15 min. At the end of incubation, the nuclear morphology of the cells was observed under fluorescence microscopy (Leica).
26)
DNA Extraction and Detection of DNA Fragments Adherent and nonadherent A375-S2 cells (1ϫ10 6 cells) were harvested, centrifuged at 1000ϫg for 10 min, and washed once in PBS. Cell pellets were lysed in 100 ml of cell lysis buffer (Tris-HCl 10 mM, pH 7.4, EDTA 10 mM, pH 8.0, 0.5% Triton X-100) at 4°C for 15 min and centrifuged at 15000ϫg for 20 min. The supernatants were incubated with proteinase K 40 mg/ml (Merck, Darmstadt, Germany) and RNase A (Sigma) 40 mg/ml at 37°C for 2 h. The lysate was extracted with NaCl 0.5 M and 50% 2-propanol, incubated at Ϫ20°C overnight, and centrifuged at 15000ϫg for 20 min. The pellets were suspended in TE buffer (Tris-HCl 10 mM, pH 7.4 and EDTA 1 mM, pH 8.0). DNA was separated by 2% agarose gel electroporesis at 100 V for 40 min and stained with ethidium bromide 0.1 mg/ml.
27)
Western Blot Analysis Immunoblotting of cell lysates was performed as previously described. 28) Both adherent and nonadherent cells were harvested, washed twice with ice-cold PBS, and then lysed in lysis buffer (HEPES 50 mM, pH 7.4, 1% Triton X-100, sodium orthovanadate 2 mM, sodium fluoride 100 mM, 1 mM EDTA, EGTA 1 mM, PMSF 1 mM, aprotinin 10 mg/ml and leupeptin 10 mg/ml) at 4°C for 60 min. The lysate was centrifuged at 15000ϫg for 10 min and the supernatant was used for Western blot analysis. Equivalent amounts of protein were separated by SDS-PAGE and wetelectrotransferred onto nitrocellulose manbranes, and equivalent loading was confirmed in the Bio-Rad protein assay. Proteins were detected with antibodies against caspase-3, -8, Bcl-2, Bax, ICAD, p53, p21
WARF and p-p53 (ser 15) (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.), and poly-ADP-ribose polymerase (PARP; Upstate Biotechnology, Lake Placid, NY, U.S.A.), followed by horseradish peroxidase (HRP)-conjugated secondary antibody (Santa Cruz Biotechnology), and visualized using 3,3-diaminobenzidine tetrahydrochloride as the HRP substrate.
Statistical Analysis Statistical analysis was conducted using Student's t-test for analysis of significance between different values. Values are expressed as meanϮS.D., and differences were considered significant at a p value of less than 0.05. All p values are two-tailed. Fig. 2 , dracorhodin perchlorate in- hibited A375-S2 cell growth in a dose-and time-dependent manner.
RESULTS
Cytotoxic Effects of Dracorhodin Perchlorate on A375-S2 Cells As shown in
Dracorhodin Perchlorate-Induced Apoptotic Cell Death in A375-S2 Cells To determine the characteristics of dracorhodin perchlorate-induced A375-S2 cell death, morphologic changes and DNA fragmentation were examined. In A375-S2 cells, exposure to dracorhodin perchlorate 60 mM for 12 h resulted in morphologic alterations characteristic of apoptosis, including membrane blebbing, nuclear condensation, and fragmentation (Figs. 3Ab, Bb). In gel electrophoresis, after 12-, 24-or 36-h treatment with dracorhodin perchlorate 60 mM, typical DNA fragmentation was observed which is another hallmark of apoptosis is (Fig. 3C) . Thus dracorhodin perchlorate induced A375-S2 cell death through apoptotic pathways.
Caspases Activated during Dracorhodin Perchlorate Induced-A375-S2 Cell Death The pan-caspase inhibitor (z-VAD-fmk) and caspase-3 (z-DEVD-fmk), -8 (z-IETDfmk), -9 (z-LEHD-fmk), and -10 inhibitors (z-AEVD-fmk) 20 mM effectively reversed dracorhodin perchlorate 60 mM-induced A375-S2 cell death (Fig. 4A) .
Western blot analysis was performed to confirm further the participation of caspase-3 and -8. The 54-kDa band of procaspase-8 and the 32-kDa band of procaspase-3 were degraded after 12-h treatment with dracorhodin perchlorate 60 mM, indicating the activation of these two caspases (Fig.  4B) .
The inhibitor of a caspase-dependent DNase (ICAD) referred to as CAD (DEF40/CPAN) is a caspase-3 substrate that is cleaved to be inactivated and allow CAD to execute the characteristic fragmentation of DNA. ICAD is expressed as two isoforms, one of 45 kDa (ICAD-L/DFF45) and one of 35 kDa (ICAD-S/DFF35). Although both ICAD-L/DFF45 and ICAD-S/DFF35 bind to and inhibit CAD, only ICAD-L/DFF45 was reported to be functional. 29, 30) Thus the ICAD-L/DFF45 expression in A375-S2 cells was examined to confirm the activation of caspase-3. After exposure to dracorhodin perchlorate 60 mM for 12 h, ICAD-L was degraded. Another characteristic associated with the execution phase of the apoptosis pathway is the specific PARP cleavage by caspases. This cleavage leads to inactivation of the enzyme, thus preventing futile DNA repair cycles. 31) It has been reported that caspase-3 is the most efficient processing enzyme for PARP. 32) Cleavage of PARP was examined after treatment with dracorhodin perchlorate. As expected, by 12 h the amount of 116-kDa protein declined and the 85-kDa degraded product increased (Fig. 4C) .
Synergistic Effects of Dracorhodin Perchlorate with Fas-Activiating Antibody CH-11 The inhibitory effects of caspase-8 and -10 inhibitors and activation of caspase-8 indicated that the death receptors may be involved in dracorhodin perchlorate-induced A375-S2 cell death. Thus dracorhodin perchlorate was simultaneously added with the Fas agonistic antibody CH-11 to cell cultures and this cotreatment induced more potent cytotoxic effects than individual drug treatment, showing synergistic effects ( Table 1) .
Involvement of Bcl-2 and Bax in Dracorhodin Perchlorate-Induced Apoptosis Since the Bcl-2 family members are critical regulators of the mitochondrial pathway that induces intrinsic activation of caspases, Western blott analysis was carried out to assess the expression of the Bcl-2 family proteins Bcl-2 and Bax. At 7 h after treatment with dra- corhodin perchlorate, the expression of Bcl-2 began to decrease, whereas that of Bax began to increase slightly (Fig.  5) .
Accumulation of p53 and p21 WAF1 in Dracorhodin Perchlorate-Induced Apoptosis As Bax expression was increased, our attention was drawn to p53 because of the existence of the p53-binding domain in the Bax gene-promoter region. 16) Treatment of A375-S2 cells with dracorhodin perchlorate 60 mM induced rapid accumulation of p53 proteins within 2 h, resulting in upregulation of the p53 downstream target gene p21 WAF1 (Fig. 6) . Furthermore, immunoblotting of serine 15-phosphorylated p53 (p-Ser-15) revealed that increased levels of p53 phoshporylation coincided with the observed increase in p53. Dracorhodin Perchlorate-Induced Phosphorylation of p38 and JNK MAPKs To determine whether MAPKs are activated during the course of apoptosis induced by dracorhodin perchlorate, we monitored the activation of three members of the MAPK family, p38, JNK54/46, and ERK42/44, using Western blot analysis with antibodies that recognize the activated phosphorylated forms of the three kinases. Dracorhodin perchlorate induced sustained phosphorylation of p38 and JNK MAPK while it maintained p-ERK at a constant level; however, the expression of total p38, JNK, and ERK MAPK was maintained at constant levels (Figs. 7A-C) . To assess the role of the sustained activation of p38 MAPK and JNK MAPK during dracorhodin perchlorate-induced apoptosis, we used the specific pharmacologic cell permeate inhibitors SB203580 for p38 and SP600125 for JNK, and both inhibitors attenuated dracorhodin perchlorate 60 mM-induced apoptosis; blocking ERK MAPK with the MEK inhibitor PD98059 augmented the cell death (Fig. 7D) .
Effects of Wortmannin and Genstein on Dracorhodin Perchlorate-Induced A375-S2 Cell Apoptosis The phos- The cells were incubated with dracorhodin perchlorate 60 mM for the indicated times. Bax and Bcl-2 were detected using Western blot analysis. The cells were incubated with dracorhodin perchlorate 60 mM for the indicated times. p53, p-p53 (ser 15), and p21 WAF1 were detected using Western blot analysis. phatidylinositol 3-kinase (PI3-K) family can phosphorylate p53 at ser-15; the PI3-K inhibitor wortmannin rescued the viability loss induced by dracorhodin perchlorate. Genistein, an inhibitor of tyrosine kinase that is an upstream activator of PI3-K, also had a protective effect against cell death (Fig. 8) .
DISCUSSION
The results of this study demonstrated that dracorhodin perchlorate inhibits the proliferation of human malignant melanoma A375-S2 cells and, based on the morphologic changes in A375-S2 cells and DNA fragmentation, that dracorhodin perchlorate induces cell death through apoptotic pathways.
Caspases are a family of proteins that play an essential role during apoptosis. The results of this study showed that pretreatment with the caspase inhibitors z-VAD-fmk, z-DEVD-fmk, z-IETD-fmk, z-LEHD-fmk, and z-AEVD-fmk effectively inhibited dracorhodin perchlorate 60 mM-induced cell death. The bands of procaspse-3 and procaspase-8 were degraded after dracorhodin perchlorate administration, followed by the degradation of caspase-3 substrates, ICAD and PARP, and the fragmentation of DNA. All these results suggest that the caspase cascade plays a critical role in dracorhodin perchlorate-mediated A375-S2 cell apoptosis. The protection against apoptosis by caspase-8 and caspase-10 inhibitors indicates that some death receptors might be involved in this event.
A balance between members of the Bcl-2 family is thought to determine whether mitochondria remain intact or become permeabilized and release proteins that promote cell death. 33) Bcl-2 forms heterodimers with a variety of proapoptotic proteins, 34) thereby preventing Bax/Bak-mediated pore formation in the outer mitochondrial membrane and the subsequent release of proapoptotic factors, including: cytochrome c, apoptosis-inducing factor (AIF), and second mitochondriaderived activator of caspases (Smac)/DIABLO. 13) Released cytochrome c binds to Apaf-1, forms the apoptosome, which proteolytically activates procaspase-9, and in turn activates the effector caspases-3, -6, and -7. In this study we found that, after 7-h dracorhodin perchlorate treatment, the expression of the antiapoptotic Bcl-2 decreased and that of the proapoptotic Bax increased. Caspse-3 activation was followed by the degradation of the caspase-3 substrates. The caspase-9 inhibitor protected the cells from dracorhodin perchlorate-induced cell death. Thus it is suggested that dracorhodin perchlorate induces A375-S2 cell apoptosis by the downregulation of Bcl-2 and upregulation of Bax, subject to the initiation of intrinsic mitochondria-apoptosome pathways.
Several studies have indicated that p53 activates the apoptotic machinery through the regulation of Bax function and mitochondrial integrity, which results in the release of cy- tochrome c and activation of caspases. 16, 35, 36) In the present study, dracorhodin perchlorate induced rapid accumulation of p53 at 2 h which was positively correlated with subsequent upregulation of Bax and resulting activation of caspase-3 and its substrates; this indicates that p53 plays a pivotal role in the initiation phase of dracorhodin perchlorate-induced A375-S2 cell apoptosis. The production of another p53 target, p21, was also upregulated. p53 has a short half-life, and phosphorylation of p53 at multiple sites is the main posttranslational modification that is regulated by several different protein kinases depending on cell type and extracellular stimuli. The protein kinases include ataxia telangiectasia mutated (ATM) 37) and the major subtypes of MAPK, i.e., ERK 1 and 2, 38) p38 kinase, 39) and JNK. 40) The serine 15 phosphorylation of p53 is the most frequent event. 41) In this study, upregulation of Ser-15 phosphorylation on p53 molecules was detected and correlated with the activation of p38 and JNK, indicating that JNK and p38 may contribute to the upregulation of serine 15 phosphorylation of p53.
JNK and P38 MAPK also play an important role in the regulation of apoptosis. Cisplatin, Taxol, 5-fluorouracil or Aplidin induces tumor cell death via activation of JNK and p38 MAPK. [42] [43] [44] [45] Activation of JNK in apoptosis leads to permeabilization of outer mitochondrial membrane, release of cytocheome c, Smac, or AIF from mitochondria to cytosol. [46] [47] [48] Sustained p38 MAPK activation contributes to UVB-induced apoptosis by mediating the release of mitochondrial cytochrome c into the cytosol. 22) In dracorhodin perchlorate induced-A375-S2 cell apoptosis, sustained activation of p38 and JNK MAPKs was detected and the p38-specific inhibitor SB 203580 and JNK-specific inhibitor SP 600125 attenuated the cell death, indicating an active role of p38 and JNK in dracorhodin perchlorate-induced A375-S2 cell apoptosis which might be related to mitochondria-mediated caspase activation. Although p-ERK remained unchanged, blockade of ERK with PD98059 potentiated dracorhodin perchlorate-induced A375-S2 cell death, suggesting that ERK MAPK is a survival mediator; this is in accordance with evodiamine-induced A375-S2 cell death. 27) The activation of p38 and JNK MAPKs in apoptosis is also linked with the induction of Fas/FasL. 49, 50) Moreover, p53 can stimulate Fas transcription, and overexpressed p53 may enhance levels of Fas at the cell surface by promoting trafficking of the Fas receptor from the Golgi apparatus. 14) Therefore the activation of p38/JNK MAPK and p53 may upregulate Fas/FasL expression and then contribute to the synergistic effects of dracorhodin perchlorate with CH-11.
In contrast to the extensively described antiapoptotic influence of PI3-K, several studies reported that activation of the PI3-K/AKT pathway sensitized the cell death response to environmental stress such as As 2 O 3 , H 2 O 2 , and tumor necrosis factor-a, and pretreatment with wortmannin blocked this process with improved cell survival. The protective effect of wortmannin in our study also reflects a proapoptotic role of PI3-K. 51, 52) It was reported that H 2 O 2 produced platelet-derived growth factor-b (PDGF-b) receptor tyrosine phosphorylation and downstream ATM kinase activation with profound p53 ser-15 phosphorylation involved in cell growth arrest and apoptosis, linking oxidative stress to p53 through the PDGF-b receptor and ATM. 53) In summary, the data presented here indicate that dracorhodin perchlorate induces apoptotic cell death in A375-S2 cells through accumulation of p53 and activation of caspases. Although p53 plays an impaortant role in integrating the death signals, the detailed upstream signals involved in phosphorylation of p53 in dracorhodin perchlorate-induced A375-S2 cells remains to be further investigated.
